28.4 C
Vientiane
Friday, August 15, 2025
spot_img
Home Blog Page 90

Thyseed Newborn Baby Bottle with Bottom Vent Design: Clinically Proven to Reduce Colic and Spit-up by 30%

New anti-colic system delivers clinically tested relief for newborn digestive discomfort

BEIJING, Aug. 6, 2025 /PRNewswire/ — Thyseed, an established name in global infant care, has announced the launch of its newborn baby bottle featuring proprietary bottom vent technology for global markets. Clinical trials confirm that this design reduces colic and spit-up by more than 30% among infants aged 0-3 months. The product is fully certified by the US FDA and relevant EU authorities, with all components passing more than 40 safety and performance tests by Swiss testing agency SGS. It is now available through premium infant care retailers across multiple countries and regions worldwide.


Targeting Feeding Challenges with Advanced Venting Technology

Colic and spit-up are common concerns for parents of newborns, whose digestive systems are still developing. To address this challenge, Thyseed’s R&D team conducted thousands of simulations to develop the bottom vent design. During feeding, the bottle’s internal pressure changes precisely control the vent’s opening and closing, preventing air from mixing into milk and forming bubbles. Clinical tests show that bottles equipped with this system provide measurable relief from feeding-related discomfort, supporting digestive wellness in early infancy. The ergonomic bottle body combined with the anti-colic system facilitates secure holding for parents and easy grasping for babies. Seamless construction eliminates dirt traps, while eco-friendly ink-printed measurement markings remain clear and durable for accurate dosing. These details enhance both practicality and safety, helping Thyseed stand out in premium markets.

High-Performance Materials for Safer Feeding Experience

The bottle offers two premium material options: BASF-engineered food-grade PPSU and high-borosilicate glass. With proven high temperature and wear resistance, both materials can withstand repeated sterilization at 180°C without release of harmful substances, complying with international safety standards, including US FDA and EU regulations. The nipple, custom-developed by Germany-based WACKER, uses a 15° angled ultra-soft silicone formulation to closely simulate the natural feel of breastfeeding, ensuring comfortable sucking while preventing nipple confusion. All materials have passed more than 40 independent safety and durability tests conducted by SGS Switzerland, delivering a safer feeding experience.

Stage-Based Design Aligned with Infant Development

Recognizing the evolving sucking abilities and swallowing rhythms during infant development, Thyseed has established a scientific stage-based feeding system. For 0-3 month infants, the stage-specific nipple features a slow milk flow rate that matches newborns’ delicate sucking strength, preventing choking while ensuring comfortable feeding at each developmental phase.

Award-Winning Innovation with Global Consumer Trust

With its outstanding design philosophy and innovative features, Thyseed’s baby bottles have earned prestigious international awards, including the Australian Good Design Award, Good Design Korea, and the Red Dot Design Award in Germany. These honors recognize Thyseed’s technological innovation, user experience, and material safety excellence.

With products available in the U.S., China, Russia, Indonesia, and other markets, the brand has gained the trust of parents and caregivers worldwide. Moving forward, Thyseed will continue to strengthen global partnerships and drive technological innovation in a move to deliver better feeding solutions for newborns worldwide.

CONTACT: zhanghuilin@thyseed.com

Thyseed Is Set to Support Southeast Asian Families with Safer Infant Feeding Solutions, Powered by Medical-Grade Technology

BEIJING, Aug. 6, 2025 /PRNewswire/ — Thyseed, an established name in global infant care, recently announced plans to introduce its premium, safety-certified feeding solutions to Southeast Asian households in 2025. With an established presence in the United States, Russia, and mainland China, Thyseed is committed to extending its industry-leading safety standards to new markets.

Since its inception, Thyseed has championed a commitment to safeguarding infants from their earliest interactions with feeding products in a move to transform infant feeding safety through profound consumer insights and groundbreaking collaborations with global material scientists. Each product embodies Thyseed’s philosophy of Design From Love, establishing the brand as the trusted innovator in premium baby care worldwide.

Brand Commitment: Safety Built on Love

Thyseed incorporates its Design From Love philosophy into every part of the brand experience. This love is shown in its strong focus on safety, believing that “every touchpoint matters in early development.” Thyseed goes beyond global safety standards, using a full safety system from raw materials to finished products. All raw materials are checked for safety, production areas meet medical-grade cleanliness standards, and finished products undergo over 40 strict tests by SGS and other trusted agencies to ensure they are free from harmful substances. This commitment also reflects a deep respect for infant development. Thyseed’s designers carefully create each product to fit the specific needs of infants from 0-3 years old, considering things like swallowing patterns, grip development, and oral-motor development, while avoiding unnecessary features and supporting natural feeding instincts.


Global Partnerships Driving Material Innovation for Infant Health

To ensure the highest safety for products that come into direct contact with infants, Thyseed has teamed up with top material suppliers. In partnership with Germany’s BASF, the company developed a special food-safe PPSU material for infants. This material stays strong even after repeated sterilization at 180°C, offers great impact resistance and clarity, and meets top safety standards like US FDA and EU EFSA certifications, preventing harmful substances from leaching out.

Thyseed also works with Germany’s WACKER to create custom medical-grade liquid silicone for nipples. This material passes 3,000 elasticity tests to ensure it stays soft, feels like breastfeeding, has low impurities, and is certified by Switzerland’s SGS for safer suckling. These collaborations go beyond simple sourcing, as they work together to create strict safety and material guidelines for infant products.

Complete Feeding System: Designed for Safe Growth from Day One

Rooted in uncompromising safety, Thyseed has engineered a comprehensive 0-3 year feeding system. The Thyseed Transition Baby Bottle series provides two material options, medical-grade PPSU and silicone. Each is improved with the breast-like nipple design that adapts to baby’s feeding style. Full-range solutions, including bottles, training cups, utensils, and pacifiers, adhere to a product development approach grounded in high-performance materials and evidence-based design principles, delivering stage-appropriate safety.

Moving forward, Thyseed will continue to safeguard babies’ first-contact safety worldwide through love-guided innovation with science-backed quality.

CONTACT: zhanghuilin@thyseed.com 

Malaysia’s US$43 Billion Potential Asset Tokenisation Opportunity

Project Juara charts way forward for all stakeholders to capture tokenisation opportunities and drive financial transformation in Malaysia.


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 6 August 2025 – Kenanga Investment Bank Berhad (“Kenanga Group“), Saison Capital Pte Ltd, Helicap Labs Pte Ltd (“HELIX“) and Satori Research Ltd, today announced the release of a white paper that offers insights into the asset tokenisation industry’s potential and its significance in driving financial transformation in Malaysia. Titled Project Juara: Malaysia’s Asset Tokenisation Opportunity (“Project Juara“) and authored by all four parties, it estimates that Malaysia’s tokenised asset market could reach US$43 billion by 2030, spanning regulated products such as unit trusts, bonds and sukuk.

From left: Ranjit Singh Gill, Director, Head of Product & Market Development, Kenanga Investors Berhad (
From left: Ranjit Singh Gill, Director, Head of Product & Market Development, Kenanga Investors Berhad (“Kenanga Investors”); Datuk Wira Ismitz Matthew De Alwis, Executive Director & Chief Executive Officer, Kenanga Investors; Datuk Chay Wai Leong, Group Managing Director, Kenanga Investment Bank Berhad; Qin En Looi, Partner, Saison Capital Pte Ltd; Teong Hng, Co-Founder & CEO, Satori Research Ltd; and Jitendra Singh Jaitawat, Co-Founder & CEO, Helicap Labs Pte Ltd.

Project Juara aligns with national interest, particularly in light of the Malaysian Prime Minister, Datuk Seri Anwar Ibrahim’s remarks in April 2025 that “with the right steps, Malaysia can position itself at the forefront of this transformation”, after discussions on the nation’s potential as a major hub for digital assets and the blockchain industry.

Against this backdrop, Project Juara charts a way towards building a robust digital asset ecosystem using a call to action and whole-of-nation approach. Traditional financial institutions can act as early adopters and counterparties to asset owners, who in turn create credible investment-worthy products. Equally important are infrastructure providers, government agencies and community leaders whose collective efforts can help shape the future of Malaysia’s digital economy to make investing inclusive, equitable and empowering for every Malaysian. The report encourages all parties to recognise that each has a distinct yet interdependent role in creating a progressive capital market landscape.

This report highlights the scale of what is possible if we take the right steps today. While digitalisation has enhanced customer interfaces and experience, tokenisation offers a deeper structural reform by reshaping how financial assets are issued, traded and governed. As such, Project Juara dives deep into examining the institutional, regulatory and technological conditions needed to unlock that potential by drawing on lessons from other markets and models across Southeast Asia. It aims to provide a roadmap that sparks dialogue and guides real action.

Kenanga Group has significantly expanded its digital footprint in recent years, not only by launching cutting-edge platforms such as Kenanga Digital Investing (KDI) and the Rakuten Trade online stockbroking platform, but also through a series of strategic investments and partnerships. This includes a stake in Kinetic DAX Sdn Bhd (KDX), one of the country’s first licensed digital asset exchanges, reinforcing its commitment to digital assets and the broader crypto ecosystem. In addition, Kenanga has invested in pioneering fintech and digital finance companies including Helicap Pte Ltd (Helicap) (data-driven private credit), Bay Group Holdings Sdn Bhd (CapBay) (supply chain financing), Merchantrade Asia Sdn Bhd (e-money and remittance services), and entered partnerships with leading technology and payment firms such as Ant Group Co, Ltd. These initiatives demonstrate Kenanga’s proactive approach to shaping Malaysia’s financial future through innovation, collaboration, and a robust presence in digital and digital asset markets.

Saison Capital Pte Ltd is the venture capital arm of Credit Saison; it invests in early stage companies across all verticals, with a focus on fintech, e-commerce and Web 3.0.

HELIX is a blockchain-based tokenisation startup founded by Helicap. HELIX enables the issuance of tokenised private credit and alternative assets.

Satori Research Ltd is a leading liquidity provider, market maker and algorithmic trader for digital assets.

For more information about Kenanga Group, please visit https://www.kenanga.com.my/.

Hashtag: #Kenanga

The issuer is solely responsible for the content of this announcement.

Kenanga Investment Bank Berhad 197301002193 (15678-H)

Established for over 50 years, Kenanga Investment Bank Berhad (“The Group“) is a leading financial group in Malaysia, offering a wide range of services, including equity broking, investment banking, treasury, Islamic banking, listed derivatives, investment management, wealth management, structured lending, and trade financing. The Group’s digital innovations include the launch of KDi GO, a wealth-centric app, along with game- changing products such as Rakuten Trade, Malaysia’s first fully digital stockbroking platform, and Kenanga Digital Investing, an A.I. robo-advisor.

Kenanga has garnered multiple awards, including top honours at the Bursa Excellence Awards 2024 and The Edge Malaysia Centurion Club 2023. The Group also secured the Top 20 Overall Excellence and the Niche Cap Excellence Award at the National Corporate Governance and Sustainability Awards 2024. As one of the highest- scoring constituents of the FTSE4Good Bursa Malaysia Index and a Participant of the United Nations Global Compact, Kenanga continues to drive collaboration, innovation, and sustainability in the financial industry.

This Press Release was issued by Kenanga Group’s Marketing, Communications & Sustainability department.

Meet SuperClean SG: Your Trusted Cleaning Partner for Healthier Homes and Offices

SINGAPORE, Aug. 6, 2025 /PRNewswire/ — If the daily grind has left your home or workspace worse for wear, SuperClean SG is here to help. This newly launched cleaning services company in Singapore is setting itself apart with reliable, eco-conscious services that promise cleaner, greener spaces without the harsh chemicals.

From cozy HDB flats to sprawling offices, SuperClean SG offers professional cleaning services with a clear focus: creating healthier environments for everyday living and working.

A New Standard in Cleaning Services Across Singapore

SuperClean SG isn’t your average cleaner. With a customer-first attitude and a focus on safe, high-quality cleaning, they’re raising the bar for cleaning services Singapore homeowners and businesses can trust. Whether it’s a light spruce-up or a thorough deep clean before a special event, every job is handled with care, consistency, and customisation.

Moreover, SuperClean SG prioritises the use of eco-friendly cleaning products that are non-toxic and safe for children, pets, and individuals with sensitivities. For clients who prefer a greener approach, these gentle yet effective products are available upon request—making SuperClean SG a trusted choice for those seeking cleaner spaces with fewer harsh chemicals.

From Homes to Offices—Supercharged Cleaning, Wherever You Need It

Need help at home? SuperClean SG provides home cleaning services Singapore families rely on, tailored to the specific needs of every space. Whether you live in a condo, HDB, or landed property, their team tackles dust, grime, and bacteria using professional methods. That’s why this service is perfect for busy professionals, parents, or elderly homeowners.

For businesses, SuperClean SG’s office cleaning services in Singapore cover everything from retail stores and clinics to educational facilities and corporate headquarters. Whether it’s daily maintenance or scheduled deep cleaning, SuperClean SG’s trained professionals ensure every space meets the highest standards of hygiene and presentation.

SuperClean SG also specialises in upholstery cleaning services for sofa, mattress, and carpet cleaning. These deep-cleaning treatments help remove embedded dust mites, allergens, stains, and odours. Thus, it improves both cleanliness and indoor air quality. It’s a popular option for families with kids, pet owners, and anyone looking to refresh high-touch furniture without harsh chemicals.

In addition, SuperClean SG offers professional aircon services to keep your cooling systems running efficiently. This includes regular aircon servicing, aircon installation for new units, and thorough aircon chemical wash services to eliminate mold, dust buildup, and bacteria inside the system. These services not only extend the lifespan of your aircon but also promote cleaner, healthier air indoors.

Their home and office clients rave about how they go beyond surface-level cleaning. Think dust mites and allergens elimination, safer air quality, and tidy spaces you can relax in. At SuperClean SG, every space matters, and every detail counts.

Flexible Cleaning Services to Fit Your Lifestyle

Life moves fast, and so should your cleaning service. SuperClean SG offers flexible packages for one-time, recurring, or post-renovation jobs without hidden fees or sneaky upselling. Everything is clearly priced, with options to suit different property types and schedules.

And yes, you can book everything directly via WhatsApp, with instant quotes and real-time support. No long forms, no phone tag; just quick, reliable help when you need it most.

Discover the SuperClean SG Promise

What truly makes SuperClean SG stand out from any other cleaning company in Singapore is its strong focus on five pillars: health, skill, eco-consciousness, service reliability, and professionalism.

This isn’t just about making places look clean. It’s about ensuring every home and office feels healthier, safer, and more comfortable to live and work in.

  1. Meticulous, Expert Cleaners with a Passion for Clean Spaces

    When you book home cleaning services Singapore residents trust, you’re not just getting a cleaner; you’re getting a trained professional who knows how to go beyond surface-level shine.

    SuperClean SG’s team is meticulous and methodical, always on the lookout for hidden dust, grime, and allergens. Whether it’s a one-off job or regular maintenance, their dedication shows in every detail.

  2. Prioritising Eco-Friendly Products That Are Safe for Families, and the Planet

    For households with young kids, pets, or allergy concerns, harsh chemicals can be a real worry. That’s why SuperClean SG prioritises the use of eco-friendly, non-toxic cleaning products, particularly for clients who prefer gentler and safer alternatives.

    From deep cleans to routine upkeep, clients have the option to request green cleaning solutions that help reduce chemical exposure while still delivering sparkling results. It’s all about keeping your space spotless without compromising on health or environmental impact.

  3. Service Quality Guarantee – Backed by Industry Standard Protocols

    From the tools they use to the way they clean, SuperClean SG operates with strict attention to punctuality, hygiene and safety. Cleaners are trained to arrive on time for every appointment, with routes and schedules carefully planned in advance to avoid delays. All cleaning routines follow national guidelines, ensuring a consistently high standard every time. That is why even though SuperClean SG is new, they are already highly rated with 5 stars for its Google Reviews.

    Not entirely happy with your cleanliness? SuperClean SG has your back. All of its professional cleaning services come with a 100% satisfaction guarantee.

    If anything is missed, just reach out to them within 24 hours. It is part of the SuperClean SG brand culture to build trust through quality and consistency.

Aligned with Singapore Green Plan 2030

More than just a buzzword, sustainability is baked into SuperClean SG’s business. SuperClean SG is taking steps to align its practices with Singapore Green Plan 2030 working towards making each cleaning job, however modest, a small contribution to a greener future.

They minimise waste, avoid harmful chemicals, and prioritise green cleaning products that are biodegradable and plant-based. That way, your space stays clean and safe—today and for generations to come.

Experience the SuperClean SG Difference, Now Available Islandwide

SuperClean SG (https://superclean.sg) is now available across the island, offering high-quality, eco-friendly cleaning services for homes and offices alike. Simply reach out via WhatsApp at +65 3129 2688 to get a quote and book your first clean in minutes. Experience what a truly professional, eco-conscious clean looks like; courtesy of SuperClean SG.

 

TECNO Renews its Partnership with Pop Culture Icon Lay Zhang as Global Brand Ambassador

JAKARTA, Indonesia, Aug. 6, 2025 /PRNewswire/ — TECNO, an AI-driven innovative technology brand, is thrilled to announce that it will continue its fruitful collaboration with Lay Zhang, which was established in 2024. This year, TECNO will strengthen its relationship with Lay by partnering with him on more diverse and exciting projects designed to resonate with young audiences.


A pop and rap artist, actor, singer-songwriter, dancer and fashion icon, Lay is an international star thanks to his talent and versatility. Each step of his career has reflected his unstoppable spirit and fearless dedication, demonstrating how greatness is achieved through determination at every step in the journey. Having started with his debut as a member of K-Pop sensation EXO in 2012, he swiftly gained popularity with audiences across Asia and in 2016 embarked on a solo career that has seen him earn numerous accolades for his exceptional flair as a performer. Showing the breadth of his talents, he also starred in the 2023 Chinese thriller movie “No More Bets,” cementing his reputation as an actor. His music career has continued to reach new heights with his blockbuster 2024 global tour, titled Grandline 4: STEP.

Lay’s relentless energy and drive have enabled him to continually push his creative limits and chase his dreams, qualities that makes him a perfect match for TECNO, a brand known for its bold ambition, constant innovation and “Stop at Nothing” mantra. Lay is also known for nurturing young talent through his entertainment agency, aligning with TECNO’s mission to empower the next generation with technology.

With his positive spirit and aspiration to continually grow, Lay mirrors the energy of TECNO’s users and is the ideal inspiration encourage them in pursuing their goals and striving for success.

“We love working with Lay because his spirit fits with ours. He understands our ambition to empower young people with technology, helping them to create opportunities, seize success and achieve a brighter, better future. He embodies the ‘Stop at Nothing’ ethos we champion,” said Laury Bai, TECNO’s Chief Marketing Officer.

Lay Zhang said he is thrilled to continue in his role for TECNO. “TECNO’s approach aligns with my quest for aspiration and creation. I’m absolutely delighted to be working with TECNO and can’t wait to share the projects we’ve got coming up.”

In addition to collaborations around brand spirit, product promotion, concert tour support and fan engagement, TECNO and Lay will join forces to create exciting content for digital and social media-savvy consumers. Recognising that music is a universal language that connects the world, Lay and TECNO will also explore shared opportunities to bring the magic of Chinese Pop music and Afrobeats to international music lovers by creating thrilling new rhythms.

As Global Brand Ambassador, Lay will showcase TECNO’s AI-enhanced POVA series, a product line renowned for its refreshing trendy design, long battery life, and gaming capabilities. With their cool, sleek, and dynamic designs, POVA products deliver a smooth entertainment and gaming experience, which Lay said he is keen to share with his followers.

Together, TECNO and Lay Zhang share a commitment to inspire and empower global consumers to get creative, express themselves and pursue their passions.

Everest Medicines Announces Full Approval of NEFECON® in Taiwan

SHANGHAI, Aug. 6, 2025 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON®. NEFECON® is indicated to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression, irrespective of proteinuria levels. 

With this label update, the previous requirement in accelerated approval stage to submit full confirmatory trial analysis to demonstrate clinical benefit has been formally removed. Additionally, data demonstrating NEFECON®‘s efficacy in delaying kidney function decline has been included in the approved product label. IgAN is highly prevalent among Asian populations, with a 56% higher risk of progression to end-stage renal disease compared to other groups and often progresses more rapidly[1]

Taiwan region became the last region across all Everest’s territories to grant full approval for NEFECON®, together with Mainland China, Singapore, Macao SAR, Hong Kong SAR and South Korea. This further demonstrates NEFECON®‘s foundational first-line cornerstone treatment for IgAN patients.

“NEFECON® has received full approval in Taiwan, further validating its outstanding clinical value and offering physicians a more solid clinical foundation for treatment decisions.” Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines, said. “As the first and only fully approved etiological treatment for IgAN, NEFECON® has now achieved full approval across Asia. This milestone will benefit a broader patient population by enabling more individuals with IgAN to access this etiological treatment earlier, helping to slow disease progression and improve quality of life. We will continue to expand the accessibility and affordability of NEFECON® across Asia, aiming to benefit more IgAN patients and improve their quality of life.”

The approval is based on the global Phase 3 NefIgArd clinical trial, which showed that compared to placebo, it not only brought about a durable reduction in proteinuria and reduced the frequency of microscopic hematuria but also demonstrated clinically relevant and statistically significant treatment benefits in estimated glomerular filtration rate (eGFR), reducing the decline in kidney function by 50% over a period of 2 years[2], comprising 9 months of treatment and 15 months of observation, and potentially delaying the progression to dialysis or kidney transplantation by 12.8 years[3].

Additionally, the complete 2-year data of the NefIgArd study[4]  further analyzed the potential differences in the response to NEFECON® treatment between Asians (n=83) and Caucasians (n=275). The results showed that compared to placebo, treatment with NEFECON® for 9 months in both Asians and Caucasians can significantly delay the decline of eGFR, protect kidney function, and bring about a sustained reduction in proteinuria and reduce the risk of microscopic hematuria.

NEFECON® has been recommended by several authoritative treatment guidelines, including the “KDIGO 2024 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) (Public Review Draft)”[5], and the “Clinical Practice Guideline for IgA Nephropathy and IgA Vasculitis in Chinese Adults (For Public Review)”. NEFECON® was included in China’s National Reimbursement Drug List (NRDL) in November 2024, and the supplemental application for the production expansion of NEFECON® has been officially approved by NMPA in August 2025.

NEFECON® is currently the world’s first IgAN treatment to have received full approval from the National Medical Products Administration (NMPA) in China, the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), the Medicines and Healthcare products Regulatory Agency(MHRA)in the United Kingdom , as well as in other Asian territories where Everest Medicines holds the rights, including Hong Kong SAR, Macao SAR, Taiwan region (China), Singapore, and South Korea.

About NEFECON®

NEFECON® is a patented oral, delayed release formulation of budesonide, a corticosteroid with potent glucocorticoid activity and weak mineralocorticoid activity that undergoes substantial first pass metabolism. The formulation is designed as a delayed release capsule that is enteric coated so that it remains intact until it releases budesonide to the distal ileum. Each capsule contains coated beads of budesonide that target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models.

In June 2019, Everest Medicines entered into an exclusive, royalty-bearing license agreement with Calliditas Therapeutics, which gives Everest Medicines exclusive rights to develop and commercialize NEFECON® in mainland China, Hong Kong SAR, Macao SAR, Taiwan (China) and Singapore. The agreement was extended in March 2022 to include South Korea as part of Everest Medicine’s territories.

About Everest Medicines

Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company’s core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website at www.everestmedicines.com

Forward-Looking Statements:

This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law.

Reference:

1. Sean J. Barbour, et al. Kidney International (2013) 84, 1017–1024.

2. Lafayette R, et al. Lancet. 2023 Sep 9;402(10405):859-870.

3. Jonathan Barratt, et al. Clinical Kidney Journal, February 2025, sfae404. https://doi.org/10.1093/ckj/sfae404

4. Jonathan Barratt, et al. 2024 WCN. Poster WCN24-1674. WCN24-1674 NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PATIENT POPULATIONS WITH IMMUNOGLOBULIN A NEPHROPATHY: A 2YEAR ANALYSIS OF THE PHASE III NEFIGARD TRIAL – ScienceDirect

5. https://doi.org/10.34067/kid.0000000583DRAFT of KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF IMMUNOGLOBULIN A NEPHROPATHY (IgAN) AND IMMUNOGLOBULIN A VASCULITIS (IgAV)

 

Eager to be bridge-builders, authors of the ‘Me and China’ writing campaign echo friendship initiatives Avenues of bonding

BEIJING, Aug. 6, 2025 /PRNewswire/ — A report from People’s Daily: On July 30, the Award Ceremony of the “Me and China” Writing Campaign and the “Silk Road•People-to-People Friendship Dialogue” Story Sharing Session were convened in Lanzhou, in Northwest China’s Gansu Province.

Award-winning participants pose for a group photo at the Award Ceremony of the
Award-winning participants pose for a group photo at the Award Ceremony of the “Me and China” Writing Campaign in Lanzhou, Northwest China’s Gansu Province, on July 30, 2025. Photo: Zhang Kaifeng/People’s Daily

The ceremony was jointly hosted by the People’s Daily and the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC), co-hosted by the Gansu Provincial People’s Association for Friendship with Foreign Countries. Representatives of the writing campaign winners from 11 countries gathered with delegates from friendship organizations, Chinese enterprises, universities, and research institutions to share touching stories of exchanges and discuss the bright prospects for people-to-people friendship.

Launched in February 2024 by the People’s Daily and the CPAFFC, the “Me and China” Writing Campaign drew extraordinary engagement. By the end of 2024, over 1,300 submissions had poured in from over 80 countries and regions.

From founding the American Flying Tiger Historical Organization to organizing visits by Flying Tigers veterans to China, and from assisting in building the Guilin Flying Tigers Heritage Park to reenacting the Hump Route despite countless obstacles – Ma Kuanchi, vice president of the American Flying Tiger Historical Organization, shared pivotal moments he had witnessed. Our relentless efforts aim to ensure that the Chinese and American people, never forget this precious history and keep the Flying Tigers’ spirit alive, he said.

Ma noted that this year marks the 80th anniversary of the victory of the Chinese People’s War of Resistance against Japanese Aggression (1931-1945) and the World Anti-Fascist War. In this significant year, we must cherish the friendship forged in blood between China and the US.

Civilizations become diverse through exchanges and enriched through mutual learning.

Vienna Cammarota, who has admired the Italian traveler Marco Polo since childhood, has long been fascinated by the ancient Silk Road. On April 26, 2022, the retired Italian tour guide set off from Venice with the book – The Travels of Marco Polo, embarking on a journey to retrace the ancient Silk Road entirely on foot. Over three years, Vienna trekked 22,000 kilometers across 15 Eurasian countries. “Every step I took was to trace the origins and resonance of civilizations. I witnessed firsthand that despite being thousands of miles apart, China and Italy are closely linked through culture,” Vienna said. 

Among the contributors to the essay collection were international students passionate about traditional Chinese culture. One of them, Zaw Win Maung from Myanmar, is studying Traditional Chinese Medicine (TCM) at Henan University of Chinese Medicine.

Zaw noted that TCM offers a different lens with which to view life: It sees humans as an integral part of nature, coexisting in harmony. “I believe I’m not just learning prescriptions or needling techniques. I’m also learning the wisdom of harmony between humanity and nature, and the tenderness and reverence toward life embedded in Chinese culture,” Zaw said.

Not long ago, Fathiya Mohamed-said, a young woman from Tanzania, graduated from School of Medicine with Jiangsu University. In her hometown, Chinese medical teams have long been praised for their compassion and professionalism. Fathiya shared that she was deeply inspired by their work: “To me, they are heroes. I’m truly proud to follow in their footsteps and become a doctor.”

“Bridge” was a recurring theme throughout the event, with many guests expressing their willingness to act as “bridge-builders,” fostering connections among peoples across borders.

“They say I’m a ‘living history’ of CSCEC Egypt,” said Hanan Othman, the administrative manager who joined the Egyptian branch of the China State Construction Engineering Corporation (CSCEC) in 1988, becoming the first Egyptian employee at the company. Today, the firm employs nearly 7,000 locals.

Over the past 37 years, Hanan has not only witnessed the company’s rapid growth, but also formed many close friendships. “I hope my friendship with Chinese colleagues can become a bridge connecting the peoples of Egypt and China.”

Fomenko Ekaterina, a Russian teacher at the China University of Petroleum, has lived and worked in China for nearly 20 years and shares an even more unique connection with the country. A chance blood donation revealed that she has Rh-negative blood – rare in China and known as “panda blood.” She immediately decided to become a regular donor and has since donated more than 4,800 milliliters.

People-to-people connectivity is the most fundamental, solid, and enduring form of connection. In just two hours, a vibrant exchange of heartfelt speeches and warm applause brought together storytellers and listeners from different cultures, testifying to the vitality of folk friendship and the ongoing momentum of people-to-people diplomacy between China and the world. 

 

240-Hour Visa-Free Transit Policy Enhances the Allure of Amazing Guizhou in Jakarta


JAKARTA, INDONESIA – Media OutReach Newswire – 6 August 2025 – Guizhou, a province renowned not only for the majestic Huangguoshu Waterfall and the mystical Mount Fanjing, is now more accessible than ever thanks to China’s 240-hour visa-free transit policy. This initiative offers greater convenience for international travelers seeking to explore the province’s rich natural beauty, vibrant ethnic culture, and technological innovation.

240-Hour Visa-Free Transit Policy Enhances the Allure of Amazing Guizhou in Jakarta
240-Hour Visa-Free Transit Policy Enhances the Allure of Amazing Guizhou in Jakarta

To further promote this policy and Guizhou’s tourism appeal, the “240-Hour Visa-Free Transit Promotion and Exchange Conference” was held in Jakarta, Indonesia, on the afternoon of August 4. Hosted by the Guizhou Provincial Department of Culture and Tourism, the event highlighted Guizhou’s diverse attractions, from shimmering Miao silverwork and the soulful Grand Songs of the Dong people to breathtaking mountain landscapes and a booming big data industry.

Ms. Wang Lin, Director of the Department’s Promotion and Exchange Division, gave a detailed briefing on the 240-hour visa-free transit policy, including its scope of application and compatible multi-destination travel products. She introduced Guizhou’s rich tourism resources, including natural wonders, architectural marvels, ethnic heritage, summer retreats, and outdoor sports. “This exchange aims to help more Indonesian tourism professionals understand Guizhou,” she said. “The visa-free transit policy is a strong catalyst for encouraging Indonesian travelers to visit. As international travel becomes more convenient with enhanced flight connectivity and smoother mobile payment experiences, tourism cooperation between Guizhou and Indonesia will deepen.”

Mr. Anton Surmali, Vice President of the Association of the Indonesian Tours and Travel Agencies (ASITA), expressed appreciation for the visa policy, noting its significance in facilitating travel between the two regions. “I’ve read about Guizhou’s stunning landscapes and unique culture in the media,” he said. “I look forward to visiting personally and believe this policy will attract more Indonesian tourists to the province.”

Ms. Wen Weiya, Director of the International Mountain Tourism Development Center of Guizhou, introduced the evolution of international mountain tourism, the structure and scale of the International Mountain Tourism Alliance (IMTA), and its development achievements. She emphasized that IMTA is committed to working with global tourism stakeholders in a spirit of equality, inclusivity, and collaboration to jointly build and share the outcomes of high-quality mountain tourism development. She warmly invited Indonesian businesses to join the alliance and participate in the upcoming International Mountain Tourism and Outdoor Sports Conference in Guizhou this November.

Mr. Wirawan Lesmana, Director of Ayo Wisata Tour, highlighted the policy’s importance in encouraging Indonesian travelers to pursue outbound tourism. “Guizhou’s rich tourism resources, combined with the visa-free advantage, offer great opportunities for collaborative product design and joint marketing to achieve mutual benefits,” he remarked.

During the event, representatives from tourism associations and travel agencies in both Guizhou and Indonesia engaged in active dialogue and idea exchange. Indonesian agencies inquired in detail about the scope of the visa-free policy and suggested leveraging social media and short video platforms to boost Guizhou’s visibility in the Indonesian market. They recommended creating customized travel packages tailored to Indonesian preferences to attract more tourists to Guizhou.

Looking ahead, Guizhou will continue to strengthen cooperation with Indonesia’s tourism industry. By leveraging the 240-hour visa-free transit policy and working closely with airlines, Guizhou aims to launch more high-quality, multi-destination travel products. These efforts will ensure that more Indonesian tourists include Guizhou in their travel itineraries, further establishing Amazing Guizhou as a world-class tourist destination.

Hashtag: #GuizhouLongxiTravelAgency

The issuer is solely responsible for the content of this announcement.